Eosinophilic dermatosis of hematologic malignancy: a case report by Almeida, FT et al.
UC Davis
Dermatology Online Journal
Title
Eosinophilic dermatosis of hematologic malignancy: a case report
Permalink
https://escholarship.org/uc/item/4k8908jb
Journal
Dermatology Online Journal, 26(3)
Authors
Almeida, FT
Caldas, R
Rodrigues, AP
et al.
Publication Date
2020
License
https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Volume 26 Number 3| March 2020| 
26(3):14 
 
 
- 1 - 
Dermatology Online Journal  ||  Photo Vignette 
Eosinophilic dermatosis of hematologic malignancy: a case 
report 
FT Almeida1, R Caldas1, AP Rodrigues2, O Ferreira1, C Brito1 
Affiliations: 1Department of Dermatovenereology, Hospital de Braga, Braga, Portugal, 2Department of Surgical Pathology, Hospital 
de Braga, Braga, Portugal 
Corresponding Author: Filipa Tavares Almeida, R. das Comunidades Lusíadas 133, 4710-243 Braga, Portugal, Tel: 351-912438376, Email: 
filipa.almeida6@hotmail.com 
 
 
 
 
Keywords: eosinophilic dermatosis of hematologic 
malignancy; eosinophil disorders; cutaneous 
manifestations of systemic disease 
 
Introduction 
Eosinophilic dermatosis of hematologic malignancy 
(EDHM) is a dermatosis characterized by tissue 
eosinophilia in the context of hematologic disease. 
This entity has previously been reported as insect 
bite-like reaction [1]. It is a rare condition with a wide 
variety of clinical presentations, ranging from 
papules, nodules, or blisters that simulate arthropod 
bites, to the formation of plaques of differing sizes 
[2].  
 
Case Synopsis 
A 71-year-old man was referred to our department 
owing to a pruritic eruption, which had been present 
for a few weeks. Significant past medical history 
included chronic lymphocytic leukemia (CLL) 
diagnosed in 2006, without need for treatment. 
During the same week, he was observed by the 
oncology department owing to new onset 
pancytopenia, leading to the diagnosis of a 
myelodysplastic syndrome (MDS). Physical 
examination revealed multiple erythemato-
violaceous papules and nodules, located on the face, 
ear helices, and neck (Figure 1). Histological 
examination revealed capillary dilatation and 
superficial perivascular and interstitial infiltration of 
polymorphonuclear inflammatory cells, with 
frequent eosinophils (Figure 2). Direct 
immunofluorescence and enzyme-linked 
immunosorbent assay studies were negative for 
bullous pemphigoid antigen-1 and bullous 
pemphigoid antigen-2, excluding bullous 
pemphigoid. Other common causes of an eosinophil 
rich infiltrate were excluded, such as infections 
(serology for human immunodeficiency virus,  
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Figure 1. Multiple erythemato-violaceous papules and nodules, 
located on the neck and right ear helix. 
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syphilis, and hepatitis virus were negative) and drug 
reaction, since he was not taking any medication. 
The patient also denied any history of insect bite; the 
diagnosis of EDHM was established. He started 
medication with oral antihistamine, but there was a 
rapid deterioration of the patient's condition leading 
to death. 
 
Conclusion 
Cutaneous involvement by an eosinophil-rich 
process may be encountered in the setting of various 
hematologic malignancies, presenting a diagnostic 
and therapeutic challenge. Although the most 
commonly associated malignancy is CLL, EDHM has 
also been associated with MDS [3]. It can precede the 
cancer diagnosis, occur concurrently, or appear 
months to years after the diagnosis [4]. Several  
therapeutic options have been attempted, such as 
antihistamines, chemotherapy, dapsone, interferon 
alpha, intravenous immunoglobulin, phototherapy, 
and radiation. Some patients report favorable 
responses to therapy, but the majority relapse or 
have an incomplete response [5]. In our case, owing 
to the fatal course, there was no possibility to 
evaluate the response to treatment. 
Given the limited data on therapeutic options and 
refractoriness of this condition, reporting such cases 
emphasizes the need for further investigation into 
more effective treatment modalities. It is important 
to recognize this dermatosis and to be aware that it 
can indicate progression of the underlying disease. 
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Figure 2. Eosinophilic dermatosis. Histological examination revealed capillary dilatation and superficial perivascular and interstitial 
infiltration of polymorphonuclear inflammatory cells. H&E, A) 100×. B) Higher magnification shows frequent eosinophils, 400×. 
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